Skip to main content Help with accessibility Skip to main navigation

DEGARELIX subcutaneous (SC) injection (Firmagon®)

Last Updated: 02 October 2018

Body System: Malignant disease

Amber retained

The Pan Mersey Area Prescribing Committee recommends the prescribing of DEGARELIX SC injection (Firmagon®) following specialist initiation for treating advanced hormone-dependent prostate cancer in people with spinal metastases in accordance with NICE TA404.